Inactive Instrument

News Stealth BioTherapeutics Corp

Equities

MITO

US85789A1051

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Stealth BioTherapeutics Corp Highlights Opportunities and Challenges in Ultra-Rare Disease Drug Development at World Orphan Drug Congress USA	23-06-14	CI
Stealth BioTherapeutics Announces Positive End-Of-Phase 2 Meeting with FDA on the Development of Elamipretide in Patients with Dry Age-related Macular Degeneration	23-06-12	CI
Stealth Biotherapeutics Enters into Exclusive Licensing Agreement with Pharmanovia to Commercialize Elamipretide	23-05-30	CI
Stealth BioTherapeutics Corp Announces Completion of Merger	22-11-17	AQ
Stealth BioTherapeutics Corp(NasdaqGM:MITO) dropped from NASDAQ Composite Index	22-11-16	CI
J. Wood Capital Advisors LLC and Morningside Venture (I) Investments Limited completed the acquisition of 22.5293% stake in Stealth BioTherapeutics Corp.	22-11-15	CI
Stealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis	22-11-02	AQ
Stealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)	22-11-01	PR
Stealth BioTherapeutics Corp Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis	22-11-01	CI
Stealth BioTherapeutics : Investor Presentation - October 2022	22-10-14	PU
Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of Shareholders	22-10-10	AQ
Stealth BioTherapeutics Announces Departure of Chief Financial Officer	22-10-03	AQ
Stealth BioTherapeutics Chief Financial Officer Departs	22-10-03	MT
Stealth BioTherapeutics Announces Departure of Chief Financial Officer	22-09-30	PR
Stealth BioTherapeutics Corp Announces Departure of Robert Weiskopf as Chief Financial Officer	22-09-30	CI
Stealth BioTherapeutics to Participate in Upcoming Ultra-Rare Disease Events	22-09-15	PR
Stealth BioTherapeutics Corp Enters Definitive Agreement for Going Private Transaction	22-08-02	AQ
Stealth BioTherapeutics Corp Agrees to Go Private; Shares Jump	22-08-01	MT
Stealth BioTherapeutics : Enters Definitive Agreement for Going Private Transaction - Form 6-K	22-08-01	PU
STEALTH BIOTHERAPEUTICS ANNOUNCES RECEIPT OF NON-COMPLIANCE NOTICE FROM NASDAQ	22-07-12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Stealth BioTherapeutics Corp

Equities

MITO

US85789A1051

Summary

Filters